Tecan maintains target for profitability and adjusts revenue guidance for 2013

Tecan maintains target for profitability and adjusts revenue guidance for 2013

ID: 304082

(Thomson Reuters ONE) -
Tecan Group AG /
Tecan maintains target for profitability and adjusts revenue guidance for 2013
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.

* Outlook for profitability improvement maintained; operating profit margin
expected to grow by around 50 basis points

* Revenue forecast adjusted to moderate sales growth in local currencies

* Confirming medium-term targets of sales around CHF 500 million with
increased profitability in 2015


Männedorf, Switzerland, October 9, 2013 - The Tecan Group (SIX Swiss Exchange:
TECN) today announced that the company continues to grow in a challenging
business environment. Tecan maintains its outlook for an increased operating
profit margin and adjusts its revenue outlook for 2013. As communicated before,
the operating profit margin is expected to grow by around 50 basis points in
2013 compared with 2012. In Tecan's Life Sciences Business division, the market
developments in North America and Europe continue to be tough and timing of end-
customer orders remain hard to predict. Based on stable sales for the Group in
the first half of 2013 and a lower than anticipated order entry in the Life
Science Business to date, the company now expects moderate growth in local
currency terms for fiscal year 2013. Previously, Tecan was targeting sales
growth to be in the mid-single-digit percentage range. The Partnering Business
continues to grow at a good level.

The current U.S. government shutdown adds additional uncertainty, potentially
delaying or putting on hold orders from federal agencies. In case the shutdown
continues for a protracted period, Tecan's 2013 results may be further impacted.

Tecan does not see the medium-term targets for 2015 communicated earlier this
year as affected by the headwinds in 2013. With important product launches ahead




in both divisions and substantial contributions to sales growth from China, the
components business and services and consumables, the major organic growth
drivers are intact. Therefore, Tecan continues to expect for 2015 at current
exchange rates sales of around CHF 500 million and an increased operating profit
margin.

About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and
solutions in biopharmaceuticals, forensics and clinical diagnostics. The company
specializes in the development, production and distribution of automated
workflow solutions for laboratories in the life sciences sector. Its clients
include pharmaceutical and biotechnology companies, university research
departments, forensic and diagnostic laboratories. As an original equipment
manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM
instruments and components that are then distributed by partner companies.
Founded in Switzerland in 1980, the company has manufacturing, research and
development sites in both Europe and North America and maintains a sales and
service network in 52 countries. In 2012, Tecan generated sales of
CHF 391 million (USD 416 million; EUR 323 million). Registered shares of Tecan
Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).


For further information:

Tecan Group
Martin Braendle
Head of Corporate Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor(at)tecan.com
www.tecan.com


Press Release (PDF):
http://hugin.info/100384/R/1734423/580905.pdf



This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Tecan Group AG via Thomson Reuters ONE
[HUG#1734423]




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Pharming announces ?12.0 million private equity placement with institutional investors Bayfield Ventures Corp. : Bayfield Drills 6.0 metres of 14.34 g/t Gold & 61.40 g/t Silver at East Burns Intrepid Zone, Rainy River District, NW Ontario
Bereitgestellt von Benutzer: hugin
Datum: 09.10.2013 - 07:20 Uhr
Sprache: Deutsch
News-ID 304082
Anzahl Zeichen: 4430

contact information:
Town:

Maennedorf



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 191 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Tecan maintains target for profitability and adjusts revenue guidance for 2013"
steht unter der journalistisch-redaktionellen Verantwortung von

Tecan Group AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Tecan Announces Change in Management Team ...

Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- -------------- * Matthi ...

Alle Meldungen von Tecan Group AG



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z